| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |